Browse and review general disease state content by therapeutic area to learn more about our work in the area of oncology.
General Oncology
Cancer Immunology
Learn more about the cancer-immunity cycle and immune checkpoints.
Bispecific Antibodies
Bispecific antibodies may play a role in tumor cell apoptosis. Learn more about how they interact with T cells.
Biomarker Testing
Biomarkers are an integral part of the clinical management of a cancer patient’s treatment journey. Learn more about how biomarker testing can detect tumor mutations and inform care management.
Liver Cancer
Liver Cancer Early Detection
Learn more about the connection between chronic liver disease and liver cancer and the importance of early detection.
Malignant Hematology
Cytokine Release Syndrome (CRS)
CRS is a potential serious adverse event of immunotherapies, particularly some T cell–engaging immunotherapies; risk mitigation and early recognition can reduce CRS severity and guide its management.
Looking for more information?
Reach out to a Genentech Medical Science Liaison near you, or connect with the contact center.
Call Us: 1-800-821-8590 Hours: Monday-Friday, 5am-5pm PT